Research and Markets (http://www.researchandmarkets.com/research/hp3lmw/angina_angina) has announced the addition of the "Angina (Angina Pectoris) - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Angina (Angina Pectoris), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Angina (Angina Pectoris) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Angina (Angina Pectoris) Overview
  3. Therapeutics Development
  4. Pipeline Products for Angina (Angina Pectoris) - Overview
  5. Pipeline Products for Angina (Angina Pectoris) - Comparative Analysis
  6. Angina (Angina Pectoris) - Therapeutics under Development by Companies
  7. Angina (Angina Pectoris) - Therapeutics under Investigation by Universities/Institutes
  8. Angina (Angina Pectoris) - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Angina (Angina Pectoris) - Products under Development by Companies
  13. Angina (Angina Pectoris) - Products under Investigation by Universities/Institutes
  14. Angina (Angina Pectoris) - Companies Involved in Therapeutics Development
  • Baxalta Incorporated
  • Bayer AG
  • Cardiolynx AG
  • Gilead Sciences, Inc.
  • Juventas Therapeutics, Inc.
  • Kuhnil Pharmaceutical Co., Ltd.
  • Lacer, S.A.
  • Lee's Pharmaceutical Holdings Limited
  • LegoChem Biosciences, Inc
  • Milestone Pharmaceuticals, Inc.
  • Taxus Cardium Pharmaceuticals Group Inc.
  • ViroMed Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/hp3lmw/angina_angina